Clinical trial Recruiting at 1 site Interventional Ages 18 and up

WHO psychological programs to support mental health in migrants resettled in Italy (ADVANCE)

Official title: Testing the Effectiveness and Implementability of WHO Psychological Intervention Strategies for Improving Mental Health Outcomes in Migrant Populations Resettled in Italy: the ADVANCE Randomized Controlled Trial

Run by Universita di Verona · NCT07209306 · Data updated 2026-11-12

This project will see if WHO's Self-Help Plus (SH+) and Doing What Matters (DWM) programs reduce anxiety and depression in migrants living in Italy who have elevated psychological distress.

More Distress, Emotional trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment237 (estimated)
SponsorUniversita di Verona
Academic / other
Locations1 site (Verona, Italy)
StatusRecruiting
StartedApril 9, 2025
Main results expectedNovember 30, 2026
Study endsApril 30, 2027
Registry record updatedOctober 6, 2025
Trial IDNCT07209306 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) living in Italy as migrants, refugees, or asylum seekers with elevated psychological distress (K10 >15.9) who can read and speak Italian or English are the ideal candidates.

Probably not a fit

People with imminent suicide risk, severe mental disorders (e.g., psychosis or substance dependence), severe cognitive impairment, acute medical conditions requiring hospitalization, or who plan to leave Italy before the six-month follow-up are unlikely to benefit in this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares WHO's Self-Help Plus (SH+) and its online version Doing What Matters (DWM) against a psychological placebo in migrants resettled in Italy who report elevated distress. Interventions are designed to be scalable and are delivered by trained non-professional helpers, with booster sessions and a guided digital option for DWM. The trial measures reductions in anxiety and depression symptoms (screening with K10 >15.9) and collects implementation outcomes to judge feasibility and scalability. Participants are adults living in Italy (including refugees, asylum seekers, and labor migrants) and are followed up to six months after randomization.

Why it matters

Potential benefit: If successful, these low-cost, scalable interventions could reduce anxiety and depression symptoms and expand accessible mental health support for many migrants in Italy and similar settings.

How similar studies have gone: Earlier randomized trials of SH+ and DWM in refugee and migrant populations showed short-term reductions in distress, but medium- to long-term effects and large-scale implementability are still not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Living in Italy temporarily or permanently as a migrant, including asylum seekers, refugees, labor migrants;
* Having elevated levels of psychological distress (K10 \>15.9);
* Sufficient mastery (written and spoken) of one of the languages the SH+/DWM intervention is being delivered in (i.e., English and/or Italian);
* Oral and written informed consent before entering the study.

Exclusion Criteria:

* Planning to permanently move back to their home country before the last follow-up assessment (at six months after randomization);

  * Having acute medical conditions (requiring hospitalization);
  * Imminent suicide risk, or expressed acute needs or protection risks that require immediate follow-up based on screening tool and clinical judgement;
  * Having a severe mental disorder (e.g., psychotic disorders, substance-dependence) based on clinical judgement;
  * Having severe cognitive impairment based on clinical judgement (e.g., severe intellectual disability or dementia);
  * Currently receiving specialized psychological treatment (e.g., Cognitive Behavioral treatment (CBT), Eye Movement Desensitizing and Reprocessing (EMDR));
  * In case of current psychotropic medication use: being on an unstable dose for at least two months.

Where it's running

  • WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
    Verona, Italy, Italy
    Recruiting

Study contacts

  • Principal investigator: Corrado Barbui, MD, Full professor — Universita di Verona
  • Study coordinator: Marianna Purgato, PhD, Associate professor
  • Email: marianna.purgato@univr.it
  • Phone: +390458124884

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.